The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.

Diniz, Juliana B

The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. [electronic resource] - Journal of psychopharmacology (Oxford, England) Jun 2014 - 603-11 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

1461-7285

10.1177/0269881113512042 doi


Adult
Antidepressive Agents, Second-Generation--adverse effects
Antidepressive Agents, Tricyclic--adverse effects
Antipsychotic Agents--adverse effects
Body Dysmorphic Disorders--diagnosis
Brazil
Clomipramine--adverse effects
Comorbidity
Drug Therapy, Combination
Female
Fluoxetine--adverse effects
Humans
Male
Obsessive-Compulsive Disorder--diagnosis
Prospective Studies
Quetiapine Fumarate--adverse effects
Risk Factors
Treatment Outcome